The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose lives ...

Growing awareness of sleep health, non-invasive treatment adoption, and technological advancements accelerate global anti-snoring devices market growth.Austin, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ...

The Global Sleep Apnea Devices Market is set to soar from USD 5.4 billion in 2023 to USD 19.65 billion by 2031, with a strong CAGR of 7.32%! WESTFORD, MA, UNITED ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

The global sleep apnea devices market is growing rapidly; it is estimated to be worth USD 13.5 billion in 2023 and is anticipated to reach over USD 20 billion by 2035. It is expected to grow at a ...

ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company's focus on healthcare technology expertise enables it ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- As healthcare moves toward proactive and at-home ...

Philips, a leading maker of CPAP machines, has agreed to pay $1.1 billion to settle lawsuits over faulty sleep apnea devices. The company said more than 58,000 people have already registered for the ...